|
|
Volumn 99, Issue 2, 2015, Pages 153-154
|
|
Treatment of diffuse subretinal fibrosis uveitis with rituximab
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIFUNGAL AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
RITUXIMAB;
STEROID;
TACROLIMUS;
CD20 ANTIGEN;
IMMUNOLOGIC FACTOR;
MONOCLONAL ANTIBODY;
ADOLESCENT;
ADULT;
CASE REPORT;
CHOROIDITIS;
DIFFUSE SUBRETINAL FIBROSIS UVEITIS;
DRUG DOSE REDUCTION;
DRUG MEGADOSE;
DRUG RESPONSE;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
ELECTRORETINOGRAPHY;
EVOKED VISUAL RESPONSE;
EYE EXAMINATION;
FEMALE;
FOLLOW UP;
FOOT DISEASE;
FUNGUS;
HUMAN;
HUMAN TISSUE;
MALE;
MIDDLE AGED;
NOTE;
PATIENT REFERRAL;
PHOTODYNAMIC THERAPY;
PLEOSPORACEAE;
RETINA DETACHMENT;
RETINA DISEASE;
RETINA MACULA CYSTOID EDEMA;
SKIN BIOPSY;
SUBFOVEAL INFLAMMATORY MEMBRANE;
SUBRETINAL FIBROSIS;
TREATMENT DURATION;
VISUAL ACUITY;
DRUG EFFECTS;
FIBROSIS;
FLUORESCENCE ANGIOGRAPHY;
OPTICAL COHERENCE TOMOGRAPHY;
PATHOLOGY;
RETINA;
UVEITIS;
ADOLESCENT;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTIGENS, CD20;
CHOROIDITIS;
ELECTRORETINOGRAPHY;
EVOKED POTENTIALS, VISUAL;
FEMALE;
FIBROSIS;
FLUORESCEIN ANGIOGRAPHY;
HUMANS;
IMMUNOLOGIC FACTORS;
MALE;
MIDDLE AGED;
RETINA;
TOMOGRAPHY, OPTICAL COHERENCE;
UVEITIS;
VISUAL ACUITY;
|
|
EID: 84921568129
PISSN: 00071161
EISSN: 14682079
Source Type: Journal
DOI: 10.1136/bjophthalmol-2013-304686 Document Type: Note |
|
Times cited : (23)
|
|
References (6)
|
